241 related articles for article (PubMed ID: 28138700)
21. MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma.
Ma C; Zhan C; Yuan H; Cui Y; Zhang Z
Oncol Rep; 2016 Jun; 35(6):3257-64. PubMed ID: 27035098
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells.
Liu M; Xiusheng H; Xiao X; Wang Y
Oncol Rep; 2016 Dec; 36(6):3371-3378. PubMed ID: 27779704
[TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNA
Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.
Vanas V; Haigl B; Stockhammer V; Sutterlüty-Fall H
PLoS One; 2016; 11(8):e0161023. PubMed ID: 27513462
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy.
Meng Y; Gao R; Ma J; Zhao J; Xu E; Wang C; Zhou X
Sci Rep; 2017 Mar; 7(1):416. PubMed ID: 28341864
[TBL] [Abstract][Full Text] [Related]
26. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
Li QC; Xu H; Wang X; Wang T; Wu J
Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
[TBL] [Abstract][Full Text] [Related]
27. miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells.
Yuan G; Zhao Y; Wu D; Gao C; Jiao Z
Future Oncol; 2018 Feb; 14(5):461-469. PubMed ID: 29327611
[TBL] [Abstract][Full Text] [Related]
28. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
Zhou B; Li L; Li Y; Sun H; Zeng C
Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255
[TBL] [Abstract][Full Text] [Related]
31. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
32. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.
Chen D; Liu D; Chen Z
Tumour Biol; 2017 Sep; 39(9):1010428317705762. PubMed ID: 28933259
[TBL] [Abstract][Full Text] [Related]
34. Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.
Zhen YF; Li ST; Zhu YR; Wang XD; Zhou XZ; Zhu LQ
Oncotarget; 2016 Nov; 7(48):79417-79427. PubMed ID: 27765904
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
36. miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells.
Wei R; Cao G; Deng Z; Su J; Cai L
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27582507
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
[TBL] [Abstract][Full Text] [Related]
38. MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.
Tian X; Zhang J; Yan L; Dong JM; Guo Q
Int J Clin Exp Pathol; 2015; 8(6):6442-9. PubMed ID: 26261520
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA‑466 inhibits cell proliferation and invasion in osteosarcoma by directly targeting insulin receptor substrate 1.
Sun Y; Zhou J; Shi L; Li J; Chen J
Mol Med Rep; 2019 Apr; 19(4):3345-3352. PubMed ID: 30816452
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.
Jiang B; Mu W; Wang J; Lu J; Jiang S; Li L; Xu H; Tian H
J Exp Clin Cancer Res; 2016 Apr; 35():69. PubMed ID: 27095063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
